COPD

A recent study found that higher temperatures were associated with worse breathing symptoms and low temperatures were associated with symptoms of bronchitis in participants with chronic obstructive pulmonary disease (COPD).

A study found that dementia was associated with patient mortality and length of stay when patients with chronic obstructive pulmonary disease (COPD) were admitted to a hospital.

A recent study found that a nurse practitioner/community health worker intervention was a feasible and acceptable strategy for addressing how social determinants of health (SDOH) and comorbidities influence chronic obstructive pulmonary disease (COPD) self-management.

According to a recent review, digital technology can be used for COPD self-management, learning correct inhaler technique, and receiving care from health care professionals.

People who have both severe mental illness (SMI) and obstructive airways disease (OAD) experience extraordinary disability and isolation, which leads to a lack of access to care and increased use of urgent care.

A recent study found that community-dwelling older adults with chronic obstructive pulmonary disease (COPD) were more likely to experience geriatric conditions.

Drugs targeting pulmonary arterial hypertension often do not have clinical or functional benefits, a meta-analysis shows, for patients with comorbid pulmonary (PH) hypertension/chronic obstructive pulmonary disease (COPD).

The data largely align with outcomes in high-income countries, with male sex and people with low body weight at particular high risk of mortality.

Measures of metabolism and energy expenditure did not appear to be associated with brown adipose tissue activation in patients with emphysematous chronic obstructive pulmonary disease (COPD).

Many patients with chronic obstructive pulmonary disease (COPD) do not believe their cases warrant emergency department care.

This new study from Spain investigated risk factors for COPD among individuals without a smoking history.

Patients with high eosinophil counts appeared to benefit from inhaled corticosteroid (ICS) therapy for chronic obstructive pulmonary disease (COPD), while those with low counts did not.

However, the differences did not translate into an increased or decreased death rate among the cohort.

A small proportion of patients have symptoms of both asthma and chronic obstructive pulmonary disease. A new report suggests there might be an intermediate phenotype.

Two common models, the CURB-65 and BAP-65, had low predictive value in determining which patients with pneumonic chronic obstructive pulmonary disease would not survive.

Investigators analyzed 12 categories of workplace agents, but only the composite category of pesticides was found to be linked with developing chronic obstructive pulmonary disease.

A lack of relationships with pulmonary rehabilitation providers and provider perceptions about patient acceptance serve as limiting factors, new research shows.

The screening tools were found to be feasible measurements and took just 7.6 minutes to complete on average.

Patients whose endurance increases will likely have a higher quality of life and ability to carry out daily functions, the authors said.

Evidence suggests higher levels of iron in pulmonary macrophages heightens the risk of infectious exacerbations.

The research suggests a computed tomography-readable biomarker could help clinicians better understand individual cases of chronic obstructive pulmonary disease.

The 30-day readmission rate among patients receiving post-hospitalization at-home interventions was roughly half the rate of a control group.

As noninvasive ventilation grows in popularity, new research examines when the therapy works, and when clinicians should be cautious.

The study points to the challenges of treating chronic obstructive pulmonary disease in a remote region in a country with a high smoking rate.

The most-read chronic obstructive pulmonary disease (COPD) articles of the year covered use of inhaled corticosteroids, palliative care for advanced COPD, and off-label prescribing of COPD therapies.